THE BIG DATA REVOLUTION
With the big data revolution, the medical and scientific communities have more information to work with than all of history combined. However, with such a wealth of information, it is increasingly difficult to differentiate productive leads from deadends.
OWKIN RESPONDS BY MAKING DATA MORE EFFICIENT.
Artificial Intelligence powered by systems biology can organize, validate, predict and compare the overabundance of information. OWKIN builds mathematical models and algorithms that can interpret omics, visual data, biostatistics and patient profiles like never before.
« WITH OWKIN, PATIENTS DIRECTLY BENEFIT WITH MORE EFFECTIVE TREATMENTS. »
Whether that means bringing new drugs to market faster, or making precision medicine commonplace. From molecule to market.
WE ACCELERATE DRUG DISCOVERY AND DISCOVER HIDDEN PATTERNS TO HELP INDIVIDUAL PATIENTS.
OWKIN IMPROVES OUTCOME VIA PREDICTIVE ANALYTICS AND MACHINE LEARNING.
OWKIN learns constantly from heterogeneous data to create unique prediction models, for example for automated diagnostics, prediction of drug response and toxicity, survival prognostics or clinical trials optimization. OWKIN understands complex data on its own, or in relation to other sets of external data and knowledge. Each patient’s data is “enriched”- meaning all other available information is overlapped, and our technology detects new pattern from this integrated picture.
OUR ALGORITHMS SOURCES PATTERNS IN THE DATA, EVEN IF THEY ARE INVISIBLE TO RESEARCHERS.
Build predictive models to uncover complex patterns of biomarkers
Design optimal molecules in silico to achieve high affinity/low toxicity
Predict drug response to design precision clinical trials with optimal outcome
Improve precision medicine finding similar patients
PREDICTION. PRECISION. PREVENTION.